29.04.2024 • Sponsored • WhitepaperBioprocessingbiopharmaceuticalsProcess Optimization

E. Coli Bioprocessing: Pioneering Advances in Biotechnology

Download this complimentary Expert Insights eBook today!

Download this complimentary Expert Insights eBook today!

This Expert Insights eBook hopes to provide scientists with more information on bioprocessing of recombinant E. coli, allowing you to further your research in recombinant protein production (RPP).

What you will learn about:

  • Gain insights into the production of artemisinin, a crucial antimalarial drug, using E. coli bioprocessing.
  • Learn about the challenges and solutions in recombinant protein production in E. coli.
  • Discover a novel strategy for efficient expression of heterologous proteins in E. coli.

PDF Cover

More Information

This eBook delves into E. coli bioprocessing, focusing on the production of artemisinin and recombinant proteins. It addresses challenges in these processes and presents innovative solutions, including a novel strategy for protein expression. The studies underscore the importance of process optimization in enhancing the efficiency of biotechnological research. Furthermore, the eBook highlights the significant implications of these advancements for the pharmaceutical industry, particularly in drug production and disease treatment.

Articles contained in the collection:

  • Patil, V. et al. (2021). Balancing glucose and oxygen uptake rates to enable high amorpha-4,11-diene production in Escherichia coli via the methylerythritol phosphate pathway. Biotechnology and Bioengineering. DOI: 10.1002/bit.27655.
  • Kumar, J. et al. (2020). Amino acid supplementation for enhancing recombinant protein production in E. coli. Biotechnology and Bioengineering. DOI: 10.1002/bit.27371.
  • Menacho-Melgar, R. et al. (2020). Scalable, two-stage, autoinduction of recombinant protein expression in E. coli utilizing phosphate depletion. Biotechnology and Bioengineering. DOI: 10.1002/bit.27440.

Get access here!

Company

IKA-Werke GmbH & Co. KG

Janke & Kunkel-Str. 10
79219 Staufen

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read